Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
Authors
Keywords
Obesity, Body mass index, Psoriasis, Psoriatic arthritis, Rheumatoid arthritis, Rheumatology, Immune response, Systematic reviews
Journal
PLoS One
Volume 13, Issue 5, Pages e0195123
Publisher
Public Library of Science (PLoS)
Online
2018-05-18
DOI
10.1371/journal.pone.0195123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adalimumab and Certolizumab Pegol for the Treatment of Crohn's Disease: Does BMI Make a Difference?
- (2018) John M. Moore et al. GASTROENTEROLOGY
- Pre-Morbid Obesity is Associated with Increased Risk of Developing Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
- (2017) Siddharth Singh et al. GASTROENTEROLOGY
- Obesity is Associated with Worse Disease Activity in Patients with Inflammatory Bowel Diseases: An Internet Based Cohort Study
- (2017) Animesh Jain et al. GASTROENTEROLOGY
- Axial spondyloarthritis
- (2017) Joachim Sieper et al. LANCET
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience
- (2016) T. Billiet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t
- (2016) J. Zweegers et al. BRITISH JOURNAL OF DERMATOLOGY
- Sa1960 Crohn's Disease Patients With High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab
- (2016) Loic Guerbau et al. GASTROENTEROLOGY
- Relationship of Body Mass Index to Clinical Outcomes after Infliximab Therapy in Patients with Crohn’s Disease
- (2016) Peter Brown et al. Journal of Crohns & Colitis
- Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
- (2016) G. S. Kaeley et al. JOURNAL OF RHEUMATOLOGY
- ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice
- (2016) Eva Vilarrasa et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study
- (2016) L. Cai et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis
- (2016) N.M. Mostafa et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
- (2016) A. Menter et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The underlying inflammatory chronic disease influences infliximab pharmacokinetics
- (2016) Christophe Passot et al. mAbs
- Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes
- (2016) Siddharth Singh et al. Nature Reviews Gastroenterology & Hepatology
- The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries
- (2016) Pil Højgaard et al. RHEUMATOLOGY
- Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
- (2016) Chang Hwan Choi et al. YONSEI MEDICAL JOURNAL
- Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2016) Yang Liu et al. ARTHRITIS CARE & RESEARCH
- Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis
- (2015) Sofia Ramiro et al. ANNALS OF THE RHEUMATIC DISEASES
- Measures of Obesity and Risk of Crohnʼs Disease and Ulcerative Colitis
- (2015) Hamed Khalili et al. INFLAMMATORY BOWEL DISEASES
- Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis
- (2015) S Upala et al. INTERNATIONAL JOURNAL OF OBESITY
- Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients
- (2015) Florenzo Iannone et al. JOINT BONE SPINE
- Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease
- (2015) Janet R. Wade et al. JOURNAL OF CLINICAL PHARMACOLOGY
- First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis
- (2015) Taku Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2015) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis
- (2015) Jeffrey A. Sparks et al. ARTHRITIS CARE & RESEARCH
- Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis
- (2015) Baodong Qin et al. ARTHRITIS RESEARCH & THERAPY
- Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
- (2015) Philip Mease et al. Arthritis & Rheumatology
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. Arthritis & Rheumatology
- Sa1925 Does Obesity Impact Treatment Efficacy of Adalimumab and Certolizumab Pegol in Crohn's Disease?
- (2015) Benjamin Click et al. GASTROENTEROLOGY
- Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis
- (2014) Maria E C Sandberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis
- (2014) Lihi Eder et al. ANNALS OF THE RHEUMATIC DISEASES
- Update on Anti-Tumor Necrosis Factor Agents in Crohn Disease
- (2014) Siddharth Singh et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations
- (2014) A. Ogdie et al. JOURNAL OF RHEUMATOLOGY
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Body weight, gender and response to TNF- blockers in axial spondyloarthritis
- (2014) E. Gremese et al. RHEUMATOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Assessing Bias in Studies of Prognostic Factors
- (2013) Jill A. Hayden et al. ANNALS OF INTERNAL MEDICINE
- Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers
- (2013) Matteo Nicola Dario Di Minno et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
- (2013) Feng Huang et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease
- (2013) Jason W. Harper et al. INFLAMMATORY BOWEL DISEASES
- Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH
- (2013) Y. Poulin et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
- (2013) Ole Haagen Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study
- (2013) Lotte Heimans et al. ARTHRITIS RESEARCH & THERAPY
- Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial
- (2012) Michael E Weinblatt et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
- (2012) A.B. Gottlieb et al. BRITISH JOURNAL OF DERMATOLOGY
- PTU-107 Weight adjusted anti-TNF therapy favours obese patients with Crohn's disease
- (2012) M Bhalme et al. GUT
- Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy
- (2012) F Iannone et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritis
- (2012) Matteo Nicola Dario di Minno et al. ARTHRITIS CARE & RESEARCH
- Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine
- (2012) Elisa Gremese et al. ARTHRITIS CARE & RESEARCH
- Body mass index influences the response to infliximab in ankylosing spondylitis
- (2012) Sébastien Ottaviani et al. ARTHRITIS RESEARCH & THERAPY
- Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients
- (2011) E. Bultman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial
- (2011) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
- (2011) Laurent Peyrin-Biroulet et al. GUT
- Inflammatory links between obesity and metabolic disease
- (2011) Carey N. Lumeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis
- (2011) Vito Di Lernia et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanercept
- (2011) Jerry Bagel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- −174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers
- (2011) Laura Di Renzo et al. Pharmacogenetics and Genomics
- Body mass index and clinical response to infliximab in rheumatoid arthritis
- (2010) Ruth Klaasen et al. ARTHRITIS AND RHEUMATISM
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation
- (2010) Samuel Bremmer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis
- (2010) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The economic burden of obesity worldwide: a systematic review of the direct costs of obesity
- (2010) D. Withrow et al. Obesity Reviews
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Adipose tissue as an endocrine organ
- (2009) Sandra Galic et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis
- (2008) Luigi Naldi et al. DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation